mab-425
mAbexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 1985 (NCT00589706)
Timeline
1980s
- Jan 1, 1985
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
EGFR inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109390 ↗
Also known as
- mab-425
- mab-425
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01317888 | N/A | Jan 1, 2010 | Drexel University |
| NCT00589706 | Phase 2 | Jan 1, 1985 | Drexel University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Drexel University | Academic/Hospital | 2 | 2 | 2 | 1985 |
1 organizations
Page 1 / 1